Last update 24 May 2025

Interleukin-6(Ajinomoto Co., Inc.)

Overview

Basic Info

Drug Type
Interleukins
Synonyms-
Target
IL-6RA
Action
agonists
Mechanism
IL-6R agonists(Interleukin-6 receptor alpha subunit agonists)
Therapeutic Areas
Hemic and Lymphatic Diseases
Active Indication-
Inactive Indication
Thrombocytopenia
Originator Organization
Ajinomoto Co., Inc.Ajinomoto Co., Inc.
Active Organization-
Inactive Organization
Ajinomoto Co., Inc.Ajinomoto Co., Inc.
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Interleukin-6(Ajinomoto Co., Inc.)
JPRN-jRCTs071200107
/ SuspendedNot ApplicableIIT
Efficacy and safety of selective JAK 1 inhibitor Filgotinib in active rheumatoid arthritis patients with inadequate response to conventional synthetic disease-modifying antirheumatic drugs: Comparative study with Filgotinib and interleukin 6 inhibitor examined by clinical index as well as musculoskeletal ultrasound assessment(TRANSFORM study): Study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial
100 Clinical Results associated with Interleukin-6(Ajinomoto Co., Inc.)
Login to view more data
100 Translational Medicine associated with Interleukin-6(Ajinomoto Co., Inc.)
Login to view more data
100 Patents (Medical) associated with Interleukin-6(Ajinomoto Co., Inc.)
Login to view more data
100 Deals associated with Interleukin-6(Ajinomoto Co., Inc.)
Login to view more data

External Link

KEGGWikiATCDrug Bank
-Interleukin-6(Ajinomoto Co., Inc.)--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ThrombocytopeniaPhase 2-
Ajinomoto Co., Inc.Ajinomoto Co., Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free